Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Treace Medical Concepts Lowers FY2025 Sales Guidance from $224.000M-$230.000M to $211.000M-$213.000M vs $227.083M Est

Author: Benzinga Newsdesk | November 06, 2025 04:11pm
Treace Medical Concepts (NASDAQ:TMCI) lowers FY2025 sales outlook from $224.000 million-$230.000 million to $211.000 million-$213.000 million vs $227.083 million estimate.

Posted In: TMCI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist